Skip to main content
SpringerLink
Log in

Attention to Prevention

  • Chapter
  • First Online:
Omega-6/3 Fatty Acids

Part of the book series: Nutrition and Health ((NH))

  • 2766 Accesses

Abstract

A major cause for excessive medical costs in the USA is excessive attention to predictive factors and neglect of causal factors. It is much better to prevent the cause than just the symptoms created by the cause. We use signs and symptoms associated with past harmful events as factors for predicting possible risk of future harm. Predicting future outcomes allows us to hope for ways that we might prevent future harm.

What’s past is prologue; what to come, in yours and my discharge.

William Shakespeare, The Tempest, Act 2, Scene 1

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 239.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 239.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lands B. A critique of paradoxes in current advice on dietary lipids. Prog Lipid Res. 2008;47:77–106.

    Article  PubMed  CAS  Google Scholar 

  2. Lands B. Planning primary prevention of coronary disease. Curr Atheroscler Rep. 2009;11(4): 272–80.

    Article  PubMed  Google Scholar 

  3. Indiana University-Purdue University, Fort Wayne (IPFW) Study, 2006; http://www.redorbit.com/news/health/788667/new_ipfw_study_finds_87_of_health_claims_lifestyle_related/. Accessed 30 Sept 2012

  4. Health Care Statistics. http://preventdisease.com/worksite_wellness/health_stats.shtml. Accessed 30 Sept 2011.

  5. Mayo Clinic report. http://www.mayoclinic.com/health/metabolic%20syndrome/DS00522/DSECTION=symptoms. Accessed 30 Sept 2012.

  6. Ross R, Glomset J, Harker L. Response to injury and atherogenesis. Am J Pathol. 1977;86(3):675–84.

    PubMed  CAS  Google Scholar 

  7. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340(2):115–26. Review. PubMed PMID: 9887164.

    Article  PubMed  CAS  Google Scholar 

  8. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999;138(5 Pt 2):S419–20. Review. PubMed PMID: 10539839.

    Article  PubMed  CAS  Google Scholar 

  9. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA. 1995;274(2):131–6.

    Article  PubMed  CAS  Google Scholar 

  10. Lands WEM, Hamazaki T, Yamazaki K, Okuyama H, Sakai K, Goto Y, et al. Changing dietary patterns. Am J Clin Nutr. 1990;51:991–3.

    PubMed  CAS  Google Scholar 

  11. Ogushi Y, Hamazaki T, Kirihara Y. Blood cholesterol as a good marker of health in Japan. World Rev. Nutr. Diet. 2009; 100: 63–70.

    Google Scholar 

  12. Lands WEM, Pitt B, Culp BR. Recent concepts on platelet function and dietary lipids in coronary thrombosis, vasospasm and angina. Herz. 1980;5:34–41.

    PubMed  CAS  Google Scholar 

  13. Lands WEM. Fish and human health. Orlando, FL: Academic; 1986.

    Google Scholar 

  14. Omega 3-6 Balance Scores. http://www.fastlearner.org/Omega3-6Balance.htm. Accessed 30 Sept 2011.

  15. Lands B, Lamoreaux E. Describing essential fatty acid balance as 3 - 6 differences rather than 3/6 ratios. Nutrition & Metabolism 2012, 9: 46-54.

    PubMed  CAS  Google Scholar 

  16. Mohrhauer H, Holman RT. Effect of linolenic acid upon the metabolism of linoleic acid. J Nutr. 1963;81:67–74.

    PubMed  CAS  Google Scholar 

  17. Lands WEM, Libelt B, Morris A, Kramer NC, Prewitt TE, Bowen P, et al. Maintenance of lower proportions of n-6 eicosanoid precursors in phospholipids of human plasma in response to added dietary n-3 fatty acids. Biochim Biophys Acta. 1992;1180:147–62.

    Article  PubMed  CAS  Google Scholar 

  18. Wada M, DeLong CJ, Hong YH, Rieke CJ, Song I, Sidhu RS, et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem. 2007;282(31):22254–66.

    Article  PubMed  CAS  Google Scholar 

  19. Lands B. Measuring blood fatty acids as a surrogate indicator for coronary heart disease. World Rev Nutr Diet. 2009;100:22–34.

    Article  PubMed  CAS  Google Scholar 

  20. Lands WE. Diets could prevent many diseases. Lipids. 2003;38(4):317–21.

    Article  PubMed  CAS  Google Scholar 

  21. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995;274(17):1363–7.

    Article  PubMed  CAS  Google Scholar 

  22. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346(15):1113–8.

    Article  PubMed  CAS  Google Scholar 

  23. Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr. 2006;83(6 Suppl):1483S–93.

    PubMed  CAS  Google Scholar 

  24. Lands B. Prevent the cause, not just the symptoms. Prostaglandins Other Lipid Mediat. 2011;96(1–4):90–3. PubMed PMID: 21827870.

    Article  PubMed  CAS  Google Scholar 

  25. Lands B. False profits and silent partners in health care. Nutr Health. 2009;20(2):79–89.

    Article  PubMed  Google Scholar 

  26. Loeppke R, Taitel M, Richling D, Parry T, Kessler RC, Hymel P, et al. Health and productivity as a business strategy. J Occup Environ Med. 2007;49(7):712–21.

    Article  PubMed  Google Scholar 

  27. De Gruttola VG, Clax P, DeMets DL, Downing GJ, Ellenberg SS, Friedman L, et al. Considerations in the evaluation of surrogate endpoints in clinical trials: summary of a National Institutes of Health Workshop. Control Clin Trials. 2001;22:485–502.

    Article  PubMed  Google Scholar 

  28. Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008;358:1431–43.

    Article  PubMed  CAS  Google Scholar 

  29. Carey J. Do cholesterol drugs do any good? Available at http://www.businessweek.com/magazine/content/08_04/b4068052092994.htm. Accessed 30 Sept 2011.

  30. Carey J. Heart disease: not about cholesterol? Available at http://www.businessweek.com/bwdaily/dnflash/content/apr2008/db20080414_688906.htm. Accessed 30 Sept 2011.

  31. Couzin J. Cholesterol veers off script. Science. 2008;322:220–3.

    Article  PubMed  CAS  Google Scholar 

  32. Steinberg D. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy. Part IV: The 1984 coronary primary prevention trial ends it—almost. J Lipid Res. 2006;47(1):1–14.

    Article  PubMed  CAS  Google Scholar 

  33. Consensus conference. Lowering blood cholesterol to prevent heart disease. JAMA. 1985;253(14): 2080–6.

    Article  Google Scholar 

  34. Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L. Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health. 1987;77(11):1417–26.

    Article  PubMed  CAS  Google Scholar 

  35. AHA Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2011 update. Circulation; 2011. Downloaded from http://circ.ahajournals.org/ on 3 Sept 2011.

  36. ACCORD Study Group, Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff Jr DC, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364(9):818–28.

    Article  PubMed  CAS  Google Scholar 

  37. Hoogwerf BJ. Action to Control Cardiovascular Risk in Diabetes Study Group: does intensive therapy of type 2 diabetes help or harm? Seeking accord on ACCORD. Cleve Clin J Med. 2008;75:729–37.

    Article  PubMed  Google Scholar 

  38. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, ­Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97. PubMed PMID: 19318384.

    Article  PubMed  Google Scholar 

  39. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto Jr AM, Kastelein JJ, et al. JUPITER Study Group: rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–207.

    Article  PubMed  CAS  Google Scholar 

  40. Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr. 2011;93(5):950–62.

    Article  PubMed  CAS  Google Scholar 

  41. Nestle M. Food politics: how the food industry influences nutrition and health. Berkeley: University of California Press; 2007.

    Google Scholar 

  42. Imhoff D. Foodfight: the citizen’s guide to a food and farm bill. Healdsburg, CA: Watershed Media; 2007.

    Google Scholar 

  43. Simon M. Appetite for profit: how the food industry undermines our health and how to fight back. New York: Nation Books; 2006.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Institute on Alcohol Abuse and Alcoholism/National Institutes of Health, United States Public Health Service, College Park, MD, USA

    Bill Lands PhD

Authors
  1. Bill Lands PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bill Lands PhD .

Editor information

Editors and Affiliations

  1. DMF Ltd Company, Luxembourg Str 46, Marche/Famenne, 6900, Belgium

    Fabien De Meester PhD

  2. Health Sciences Center, Department of Health Promotion Sciences, University of Arizona, 1295 N. Martin Ave. 1295, Tucson, 85724-5155, Arizona, USA

    Ronald Ross Watson PhD

  3. Division of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, University of Arizona, 1295 N. Martin Avenue, Tucson, 85724, Arizona, USA

    Sherma Zibadi PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lands, B. (2013). Attention to Prevention. In: De Meester, F., Watson, R., Zibadi, S. (eds) Omega-6/3 Fatty Acids. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-215-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-215-5_2

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-214-8

  • Online ISBN: 978-1-62703-215-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation